Zhang Y - Search Results

1

The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.

Zhang Y, Wang HB, Chi LJ, Wang WZ. Zhang Y, et al. Immunol Lett. 2009 Jan 29;122(1):52-7. doi: 10.1016/j.imlet.2008.11.015. Epub 2008 Dec 25. Immunol Lett. 2009. PMID: 19111574

2

Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.

Chi LJ, Wang HB, Zhang Y, Wang WZ. Chi LJ, et al. Among authors: zhang y. J Neuroimmunol. 2007 Dec;192(1-2):206-14. doi: 10.1016/j.jneuroim.2007.09.034. Epub 2007 Nov 13. J Neuroimmunol. 2007. PMID: 17997492

3

[The role of CD4+ CD25+ T cells in the mechanism of myasthenia gravis in children and adults].

He XT, Liu WB, Feng HY, Zhang Y, Huang X, Meng R, Wu CY. He XT, et al. Among authors: zhang y. Zhonghua Yi Xue Za Zhi. 2008 Dec 9;88(45):3189-91. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19171090 Chinese.

4

[Correlation between pathogenesis of myasthenia gravis and thymus mature dendritic cells].

Xia Q, Liu WB, Feng HY, Chen ZG, Zhang Y, He XT. Xia Q, et al. Among authors: zhang y. Zhonghua Yi Xue Za Zhi. 2008 Dec 23;88(47):3349-51. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19257967 Clinical Trial. Chinese.

5

[Expression of regulatory T cells in thymus of myasthenia gravis patients].

Xia Q, Liu WB, Chen ZG, Zhang Y, He XT, Huang RX. Xia Q, et al. Among authors: zhang y. Zhonghua Yi Xue Za Zhi. 2009 Nov 24;89(43):3031-4. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20137627 Clinical Trial. Chinese.

6

[Mediation of cellular immune response by TP5 in pathogenesis of myasthenia gravis].

He XT, Liu WB, Zhang Y, Huang X, Huang RX. He XT, et al. Among authors: zhang y. Zhonghua Yi Xue Za Zhi. 2009 Dec 22;89(47):3337-40. Zhonghua Yi Xue Za Zhi. 2009. PMID: 20193562 Chinese.

7

Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients.

Li FJ, Zhang Y, Jin GX, Yao L, Wu DQ. Li FJ, et al. Among authors: zhang y. Immunol Lett. 2013 Feb;150(1-2):116-22. doi: 10.1016/j.imlet.2012.12.004. Epub 2012 Dec 20. Immunol Lett. 2013. PMID: 23261718

8

Application Prospect of Artificial Intelligence in Rehabilitation and Management of Myasthenia Gravis.

Zhang Y, Yu H, Dong R, Ji X, Li F. Zhang Y, et al. Biomed Res Int. 2021 Mar 4;2021:5592472. doi: 10.1155/2021/5592472. eCollection 2021. Biomed Res Int. 2021. PMID: 33763475 Free PMC article. Review.

9

[Prognostic factors related to recurrence after extended thymectomy in patients with myasthenia gravis].

Men LN, Liu WB, Chen ZG, He XT, Zhang Y, Huang R. Men LN, et al. Among authors: zhang y. Zhonghua Yi Xue Za Zhi. 2008 Jun 3;88(21):1446-9. Zhonghua Yi Xue Za Zhi. 2008. PMID: 18953847 Chinese.

10

[Analysis of prognostic factors and efficacy of plasmapheresis in the treatment of myasthenia crisis].

Feng HY, Liu WB, Qiu L, He XT, Zhang Y, Huang X, Huang RX. Feng HY, et al. Among authors: zhang y. Zhonghua Yi Xue Za Zhi. 2010 Dec 21;90(47):3343-6. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21223750 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261,271 results

Search Page

Filters